Brief: FDA Aware Of Merit Medical Urging Removal Of Some Dialysis Catheters From Use/Sale
April 14 (Reuters) - FDA: FDA: AWARE THAT MERIT MEDICAL ISSUED LETTER TO AFFECTED CUSTOMERS RECOMMENDING SOME DIALYSIS CATHETERS BE REMOVED FROM WHERE THEY ARE USED/SOLD FDA: AS OF FEB 23, MERIT MEDICAL HAS REPORTED TWO SERIOUS INJURIES & NO DEATHS ASSOCIATED WITH SOME DIALYSIS CATHETERS Further company coverage: MMSI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Merit Medical Systems
See all newsMerit Medical Systems Inc reports results for the quarter ended March 31 - Earnings Summary
Merit Medical Q2 adjusted EPS beats estimates, raises 2026 outlook
Brief: Merit Medical Systems Q2 Adjusted EPS USD 1.19 Vs. IBES Estimate USD 0.96
Brief: Merit Medical Shareholders Elect Scott R. Ward To Board Of Directors
Merit Medical Q1 adjusted EPS rises on therapeutic, foundational growth